¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Obesity research."¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® obesity ÇÑ±Û ºñ¸¸Áõ
¼³¸í   
  ½Åü¿¡ Áö¹æÀÌ °úÀ×À¸·Î ÃàÀûµÇ¾î °ñ°Ý»ó ¹× À°Ã¼»ó ¿ä±¸ÀÇ ÇѰè ÀÌ»óÀ¸·Î Ã¼ÁßÀÌ Áõ°¡µÈ »óÅÂÀÌ´Ù. ±×·¯³ª Ã¼Áö¹æÀÇ ÃøÁ¤Àº ½±Áö ¾Ê±â ¶§¹®¿¡ ¼öºÐ·ù³ª ±ÙÀ°Áõ°¡ÀÇ °æ¿ì¸¦ »©°í, ÀϹÝÀûÀ¸·Î´Â Ã¼ÁßÁõ°¡¿Í µ¿ÀǾî·Î »ý°¢µÇ¾î Ç¥ÁØÃ¼Áß(ÀÌ»óüÁß)À» 10~20% ³Ñ´Â °æ¿ì¸¦ ºñ¸¸À̶ó Á¤ÀÇÇÑ´Ù. Èí¼ö Ä®·Î¸®°¡ ¼Òºñ Ä®·Î¸®¸¦ ³ÑÀ» ¶§´Â ±× Â÷¸¦ Áß¼ºÁö¹æÀ¸·Î Çؼ­ Áö¹æ¼¼Æ÷¿¡ ÃàÀûµÇ¾îÁö´Â °á°ú Ã¼Áö¹æÀÌ Áõ°¡ÇÑ´Ù. Äí½ÌÁõÈıº, ½Ã»óÇϺμջó µî¿¡µµ ºñ¸¸ÀÌ ³ªÅ¸³­´Ù. ºñ¸¸, Æ¯È÷ º¹ºÎ ºñ¸¸Àº ¿©·¯ Áúȯ, Æ¯È÷ ¼ºÀκ´À̶ó°í Çϴ ÁúȯÀÇ ¹ß»ý°ú °ü·ÃÀÌ Àִ °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. ºñ¸¸µµÀÇ Æò°¡¿¡´Â Ã¼ÁßÀ» ÃøÁ¤Çϴ ¹æ¹ý, ÇǺÎÁÖ¸§µÎ²² ÃøÁ¤¹ý(͏®ÆÛ¸¦ »ç¿ë)ÀÌ ÀÖ´Ù. ºñ¸¸µµ Áö¼ö¸¦ Æò°¡Çϴ ÀÓ»óÀûÀΠ¹æ¹ý¿¡´Â ÀÌ»óüÁß¹ý(modified Broca's method)À¸·Î °¡Àå ½±°Ô »ç¿ëÇϴ ¹æ¹ýÀ̸ç [½ÅÀå(cm)£­100]¡¿0.9¸¦ ÀÌ»óüÁßÀ¸·Î °è»êÇÏ¿© ÇöÀçüÁßÀ» ¹éºÐÀ²È­½ÃŲ ¹æ¹ýÀÌ´Ù. ºñ¸¸µµ = (½ÇÃøÃ¼Áߣ­Ç¥ÁØÃ¼Áß)/Ç¥ÁØÃ¼Áß¡¿100%·Î °è»êÇÑ´Ù. ºñ¸¸ÀÇ ¿øÀÎÀ¸·Î´Â À¯ÀüÀû ¿äÀÎ, È¯°æÀû ¿äÀÎ, ¿¡³ÊÁö ´ë»çÀÇ ÀÌ»ó µîÀÌ ÀÖ´Ù. ºñ¸¸ÀÇ Á¾·ù¿¡´Â ¿øÀο¡ µû¶ó¼­, ´Ü¼ø ºñ¸¸°ú ÁõÈļº ºñ¸¸À¸·Î ºÐ·ùÇÒ ¼ö ÀÖ´Ù. ´Ü¼ø ºñ¸¸Àº °ú½Ä°ú ¿îµ¿ ºÎÁ·ÀÌ ±× ¿øÀÎÀ̸ç, ÁõÈļº ºñ¸¸Àº ³»ºÐºñ, ½Ã»óÇϺμº, À¯Àü ¹× ´ë»ç¼º µîÀ¸·Î ¹ß»ýÇÑ´Ù.
¿µ¹® VDRL(venereal disease research laboratory) ÇÑ±Û ¼ºº´ ¿¬±¸½ÇÇè½Ç
¼³¸í   
  ¸Åµ¶±ÕÀÇ reagin¿¡ ´ëÇÑ Ç×ü. ¸Åµ¶ÀÇ ¼±º°°Ë»ç·Î »ç¿ëµÇ¸ç ¸Åµ¶ Ä¡·á¿¡ ´ëÇÑ ¹ÝÀÀ ¿©ºÎ¿Í Ä¡·áÈ¿°ú ÆÇÁ¤¿¡µµ »ç¿ëµÈ´Ù. ¸Åµ¶¿Ü¿¡µµ Àü½Å¼ºÈ«¹Ý¼º³¶Ã¢, ·ù¸¶Æ¼½º°üÀý¿° µî¿¡¼­µµ ¾ç¼ºÀ¸·Î ³ªÅ¸³¯ ¼ö ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • research
    ¿¬±¸
  • research design
    ¿¬±¸°èȹ
  • research diagnostic criteria
    ¿¬±¸Áø´Ü±âÁØ
  • venereal disease research laboratory test
    ¸Åµ¶Ç÷û°Ë»ç, VDRL°Ë»ç
  • adult-onset obesity
    ¼ºÀιߺ´ºñ¸¸
  • alimentary obesity
    ½Ä»çºñ¸¸
  • android obesity
    ³²¼ºÇüºñ¸¸
  • exogenous obesity
    ¿ÜÀκñ¸¸, ½Ä»çºñ¸¸
  • endogenous obesity
    ³»Àκñ¸¸, ´ë»çºñ¸¸
  • hyperplasmic obesity
    ÇüÁúÁõ½Äºñ¸¸
  • hypogonadal obesity
    »ý½Ä»ùÀúÇϺñ¸¸
  • hypothalamic obesity
    ½Ã»óÇϺκñ¸¸
  • morbid obesity
    º´Àûºñ¸¸
  • obesity
    1. ºñ¸¸ 2. ºñ¸¸Áõ
  • obesity index
    ºñ¸¸Áö¼ö
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • obesity index
    ºñ¸¸Áö¼ö
  • obesity
    ºñ¸¸, ºñ¸¸Áõ
  • research
    ¿¬±¸
  • diagnostic research
    Áø´Ü¿¬±¸
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • research diagnostic criteria
    ¿¬±¸Áø´Ü±âÁØ
  • research design
    ¿¬±¸°èȹ
  • operational research
    ÀÛÀü¿¬±¸
  • research
    ¿¬±¸
  • venereal disease research laboratory test
    ¸Åµ¶Ç÷û°Ë»ç
  • alimentary obesity
    (¢¡exogenous obesity) ½Ä»çºñ¸¸
  • endogenous obesity
    ´ë»çºñ¸¸
  • exogenous obesity
    ½Ä»çºñ¸¸
  • hyperplasmic obesity
    Ç÷ÀåÁõ½Äºñ¸¸Áõ
  • hypogonad obesity
    ¼º±â´ÉÀúÇϺñ¸¸(Áõ)
  • hypothalamic obesity
    ½Ã»óÇϺκñ¸¸(Áõ)
  • obesity index
    ºñ¸¸Áö¼ö
  • morbid obesity
    º´Àûºñ¸¸
  • obesity
    ºñ¸¸(Áõ)
  • paradoxical obesity
    ±âÀ̺ñ¸¸
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Lipid Research Clinic
    ÁöÁú¿¬±¸Áø·á¼Ò
  • RDC, see Research Diagnostic Criteria
    ¿¬±¸Áø´Ü±âÁØ, ¿¬±¸¿ë Áø´Ü±âÁØ
  • VDRL test= venereal disease research laboratory test
    ¼ºº´¿¬±¸¼Ò½ÄÅ×½ºÆ®.
  • VDRL test= venereal disease research laboratory test
    ¼ºº´¿¬±¸¼Ò½ÄÅ×½ºÆ®.
  • Hypothalamic obesity
    ½Ã»óÇϺκñ´ëÁõ(ÝþÓÞñø)
  • adrenocortical obesity
    ºÎ½ÅÇÇÁú¼º ºñ¸¸(Áõ)(¡­àõÝþØ»ñø).
  • hyperplasmic obesity
    Ç÷ÀåÁõ½Ä¼º ºñ¸¸Áõ(úìíìñòãÖàõÝþØ»ñø).
  • hypothalamic obesity
    ½Ã»óÇϺμº ºñ¸¸(Áõ)(¡­ÝþØ»ñø).
  • pituitary obesity
    Çϼöü¼º ºñ¸¸Áõ(¡­ÝþØ»ñø).
  • pituitary obesity
    Çϼöü¼º ºñ¸¸Áõ(ù»á÷ô÷àõ ÝþØ»ñø)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • research diagnostic criteria(RDC)
    ¿¬±¸Áø´Ü±âÁØ
  • venereal disease research laboratory test =VDRL test
    ¼ºº´¿¬±¸¼Ò½ÄÅ×½ºÆ®.
  • venereal disease research laboratory test =VDRL test
    ¼ºº´¿¬±¸¼Ò½ÄÅ×½ºÆ®.
  • adrenocortical obesity
    ºÎ½ÅÇÇÁú¼º ºñ¸¸(Áõ)(¡­àõÝþØ»ñø).
  • central obesity
    Á߽ɺκñ¸¸(Áõ), ±¸°£ºñ¸¸.
  • exogenous obesity
    ¿ÜÀμº ºñ¸¸Áõ.
  • hyperplasmic obesity
    Ç÷ÀåÁõ½Ä¼º ºñ¸¸Áõ(úìíìñòãÖàõÝþØ»ñø).
  • hypogonadal obesity
    ¼º±â´ÉÀúÇϼº ºñ¸¸(Áõ).
  • hypothalamic obesity
    ½Ã»óÇϺμº ºñ¸¸(Áõ)(¡­ÝþØ»ñø).
  • morbid obesity
    º´Àû ºñ¸¸
  • obesitas =obesity
    ºñ¸¸(Áõ)(ÝþØ»ñø).
  • obesity
    ºñ¸¸(Áõ)
  • obesity
    ºñ¸¸(ÝþØ»), ºñ¹Ý(Ýþ?)
  • obesity
    ºñ¸¸Áõ
  • obesity diet
    ºñ¸¸Áõ½ÄÀÌ(¡­ãÝìÈ).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • obesity
    ºñ¸¸(ÝþØ»)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • obesity
    ºñ¸¸(Áõ)
  • pituitary obesity
    Çϼöü¼ººñ¸¸Áõ
  • truncal obesity
    Á߽ɼººñ¸¸
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
COI Central Obesity Index; certificate of insurance; cost of illness
HHHO hypotonia, hypomentia, hypogonadism, obesity [syndrome]
MO macroorchidism; manually operated; Master of Obstetrics; Master of Osteopathy; medical officer; mesi...
MOMO macrosomia-obesity-macrocephaly-ocular abnormalities [syndrome]
OB obese [mouse]; obese, obesity; objective benefit; obliterative bronchiolitis; obstetrics, obstetrici...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
DIO Diet-induced obesity
OHS Obesity Hypoventilation Syndrome
%OB obesity
ARCI Addiction Research Center Inventory
AHCPR Agency for Health Care Policy and Research
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • JrId: 8604
    JournalTitle: Obesity research.
    MedAbbr: Obes Res
    ISSN: 1071-7323
    ESSN:
    IsoAbbr: Obes. Res.
    NlmId: 9305691
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • adrenocortical obesity
    ºÎ½Å ÇÇÁú¼º ºñ¸¸, ºÎ½Å ÇÇÁú¼º ºñ¸¸Áõ
  • hypogonadal obesity
    ¼º ±â´É ÀúÇϼº ºñ¸¸, ¼º ±â´É ÀúÇϼº ºñ¸¸Áõ
  • obesity
    ºñ¸¸, ºñ¸¸Áõ
    1. ½Åü¿¡ Áö¹æÀÇ °úµµÇÑ ÃàÀûÀ¸·Î °ñ°Ý°ú À°Ã¼ÀÇ ¿ä±¸ ÇѰ踦 ³Ñ¾î¼­¼­ ¸ö¹«°Ô°¡ Áõ°¡ÇÏ´Â °Í. 2. Áö¹æ Á¶Á÷ÀÇ ´ë»ç Àå¾Ö¿¡ ÀÇÇÏ¿© Áö¹æÀÇ ¿¬¼Ò°¡ ºÒÃæºÐÇÏ°Ô µÇ¾î ½ÅüÀÇ ¿©·¯ °÷¿¡ Áö¹æÀÇ ÀÌ»ó Ä§ÂøÀÌ ÀϾ´Â Áõ¼¼. Áö¹æ °ú´ÙÁõÀ̶ó°íµµ ÇÑ´Ù. ´ë°³´Â ³»ºÐºñ¼±ÀÇ ÀÌ»ó, ¶Ç´Â ³»ºÐºñ¼± »óÈ£°£ÀÇ ÀÌ»ó¿¡ ±âÀÎÇÑ´Ù. ¿¹¸¦ µé¸é, ¼º¼±¼º ºñ¸¸º´, °©»ó¼± ±â´É ÀúÇϳª, ºÎ½Å ÇÇÁú ±â´É Ç×Áø, Çϼöü °£³ú°è Àå¾Ö¿¡ ÀÇÇÑ ºñ¸¸ÁõÀÌ ÀÖÀ¸¸ç, À̵éÀ» ³»Àμº ºñ¸¸ÁõÀ̶ó°í ÇÑ´Ù. À̰Ϳ¡ ´ëÇØ °úµµÀÇ ¿µ¾ç ¼·Ãë·Î ÀÎÇÑ °ÍÀ» ¿ÜÀμº ºñ¸¸ÁõÀ̶ó°í ÇÑ´Ù. 3. ÈçÇÑ ¹®Á¦À̳ª Áõ¸íÇÒ ¸¸ÇÑ ³»ºÐºñÀû ¿øÀÎÀº µå¹°¸ç, ÈçÈ÷ ´Ù¸¥ ¿øÀο¡ ÀÇÇÑ´Ù. ½ÅüÀû Ȱµ¿ ÀúÇÏ¿¡ ÀÇÇØ¼­ ¾à°£ÀÇ Ã¼Áß Áõ°¡°¡ À¯¹ßµÇ¸ç ³ëÈ­µµ ºñ¸¸Áõ¿¡ ¿ªÇÒÀ» ÇÑ´Ù. Áï 20¼¼¿¡¼­ 63¼¼ »çÀÌÀÇ ¼ºÀο¡¼­´Â ¿¬°£ 0.1kg/§³ÀÇ Ã¼Áß Áõ°¡°¡ ÀÖ´Ù. À¯ÀüÀº °¡Àå Áß¿äÇÑ ºñ¸¸ÁõÀÇ °áÁ¤ ÀÎÀÚÀÌ´Ù. ½ÖµÕÀÌ ¿¬±¸¿¡ ÀÇÇÏ¸é ºñ¸¸ÁõÀÇ 70%´Â À¯ÀüÀû ÀÎÀÚ¿¡ ÀÇÇÑ´Ù´Â °ÍÀÌ ½Ã»çµÇ¾ú´Ù. ºñ¸¸ÁõÀ» Á¶ÀýÇÏ´Â À¯Àü ÀÎÀÚ
  • paradoxical obesity
    ±âÀÌ ºñ¸¸Áõ
  • truncal obesity
    Á߽ɼº ºñ¸¸
  • clinical research
    ÀÓ»ó ¿¬±¸
  • pain research laboratory
    µ¿Åë ¿¬±¸¼Ò
  • preclinical research
    ÀÓ»ó Àü ¿¬±¸
  • research
    ¿¬±¸, Á¶»ç
  • The National Institute of Dental Research
    ±¹¸³ Ä¡ÀÇÇÐ ¿¬±¸¼Ò
  • VDRL : Venereal Disease Research LaboratoryÀÇ ¾àÀÚ. ¸Åµ¶±ÕÀÇ Reagin¿¡ ´ëÇÑ Ç×ü·Î, ¸Åµ¶ÀÇ ¼±º°°Ë»ç·Î »ç¿ëµÇ¸ç ¸Åµ¶ Ä¡·á¿¡ ´ëÇÑ ¹ÝÀÀ ¿©ºÎ°¡ Ä¡·á È¿°ú ÆÇÁ¤¿¡ »ç¿ëµÈ´Ù. ¸Åµ¶ ¿Ü¿¡µµ Àü½Å¼º È«¹Ý¼º ³¶Ã¢(SLE), ·ù¸¶ÅäÀÌµå °üÀý¿° µî¿¡¼­µµ ¾ç¼ºÀ¸·Î ³ªÅ¸³¯ ¼ö ÀÖ´Ù.
    VDRL ¸é»ó ¹ÝÀÀ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
anti-obesity agents Agents that increase energy expenditure and weight loss by neural and chemical regulation. Beta-adrenergic agents and serotoninergic drugs have been experimentally used in patients with non-insulin dependent diabetes mellitus (niddm) to treat obesity.
(12 Dec 1998)
central obesity The deposition of obesity around the trunk sparing the limbs.
(27 Sep 1997)
risks, obesity-related Obesity increases the risk of developing a number of diseases including: type 2 (adult-onset) diabetes high blood pressure (hypertension) stroke (cerebrovascular accident or cva) heart attack (myocardial infarction or mi) heart failure (congestive heart failure) cancer (only certain forms such as prostate and colon cancer) gallstones and gall bladder disease (cholecystitis) gout and gouty arthritis osteoarthritis (degenerative arthritis) of the knees, hips, and the lower back sleep apnea (failure to breath normally during sleep, lowering blood oxygen) pickwickian syndrome (obesity, red face, underventilation, and drowsiness)
(12 Dec 1998)
morbid obesity Obesity sufficient to prevent normal activity or physiologic function, or to cause the onset of a pathologic condition.
Simple obesity, obesity resulting when caloric intake exceeds energy expenditure.
(05 Mar 2000)
hypothalamic obesity with hypogonadism A disorder characterised primarily by obesity and hypogonadotrophic hypogonadism in adolescent boys; dwarfism is rare, and when present is thought to reflect hypothyroidism. Visual loss, behavioural abnormalities, and diabetes insipidus may occur. Frohlich's syndrome often is used synonymously for this disorder, although the original case involved a pituitary tumour; most cases are thought to result from hypothalamic dysfunction in areas regulating appetite and gonadal development. The most common causes are pituitary and hypothalamic neoplasms.
Synonym: adiposis orchica, adiposogenital degeneration, adiposogenital dystrophy, adiposogenital syndrome, hypophysial syndrome, hypothalamic obesity with hypogonadism.
Origin: L. Fr. G. Dys-, bad, + trophe, nourishment
(05 Mar 2000)
diseases, obesity-related Obesity increases the risk of developing a number of diseases including: Type 2 (adult-onset) diabetes High blood pressure (hypertension) Stroke (cerebrovascular accident or CVA) Heart attack (myocardial infarction or MI) Heart failure (congestive heart failure) Cancer (only certain forms such as prostate and colon cancer) Gallstones and gall bladder disease (cholecystitis) Gout and gouty arthritis Osteoarthritis (degenerative arthritis) of the knees, hips, and the lower back Sleep apnea (failure to breath normally during sleep, lowering blood oxygen) Pickwickian syndrome (obesity, red face, underventilation, and drowsiness).
(12 Dec 1998)
obesity <clinical sign> An increase in body weight beyond the limitation of skeletal and physical requirement, as the result of an excessive accumulation of fat in the body.
Origin: L. Obesus = fat
(18 Nov 1997)
obesity index Body weight divided by body volume.
(05 Mar 2000)
obesity, morbid The condition of weighing two, three, or more times the ideal weight, so called because it is associated with many serious and life-threatening disorders.
(12 Dec 1998)
obesity-related diseases Obesity increases the risk of developing a number of diseases including: type 2 (adult-onset) diabetes high blood pressure (hypertension) stroke (cerebrovascular accident or cva) heart attack (myocardial infarction or mi) heart failure (congestive heart failure) cancer (only certain forms such as prostate and colon cancer) gallstones and gall bladder disease (cholecystitis) gout and gouty arthritis osteoarthritis (degenerative arthritis) of the knees, hips, and the lower back sleep apnea (failure to breath normally during sleep, lowering blood oxygen) pickwickian syndrome (obesity, red face, underventilation, and drowsiness).
(12 Dec 1998)
Venereal Disease Research Laboratory <microbiology> A blood test used to diagnose syphilis.
Read as nonreactive or negative if you do not have syphilis. The Venereal Disease Research Laboratory can also be positive is cases of leprosy, malaria, mononucleosis, lupus, hepatitis A and pregnancy.
Positive Venereal Disease Research Laboratory tests are usually followed up by a more specific test (FTA antibodies).
(12 Jan 1998)
Medical Research Council <organisation> A UK Government funded body to promote the balanced development of medical and related biological research in the United Kingdom.
It organises national clinical trials for the assessment of new treatment protocols for leukaemia and some of the related diseases.
(05 Jan 1998)
research Careful, a diligent search, a close searching, studious inquiry or examination.
(18 Nov 1997)
research, controlled The first controlled clinical research was probably done in 1875 by the british naval surgeon james lind who, on board the hms salisbury, gave sailors with scurvy either oranges or lemons or cider or vinegar or nutmeg (or another treatment) and after just six days discovered that the citrus-consuming sailors had recovered from scury, until then the scourge of extended sea voyages, while the sailors who had been given the other treatments remained uncured.
(12 Dec 1998)
research design A plan for collecting and utilizing data so that desired information can be obtained with sufficient precision or so that an hypothesis can be tested properly.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • obesity
    ºñ¸¸;ºñ´ë
  • research
    ¿¬±¸
  • listener research
    Àαâ ÇÁ·ÎÁ¶»ç
  • market research
    (Á¦Ç°À» ¸ÅÃâÇϱâ ÀüÀÇ) ½ÃÀå Á¶»ç
  • market research
    ½ÃÀå Á¶»ç (¾î¶² »óǰÀÇ ¼ö¿ä¸¦ À§ÇÑ »çÀü Á¶»ç)
  • marketing research
    ½ÃÀå Á¶»ç;½ÃÀå ºÐ¼®
  • motivational research
    µ¿±â Á¶»ç
  • operations research
    ±â¾÷ °æ¿µ»óÀÇ °úÇÐÀû Á¶»ç ¿¬±¸;ÀÛÀü ¿¬±¸
  • research
    (Çмú)¿¬±¸;°úÇÐÀû ޱ¸;ÇмúÁ¶»ç;(½ÅÁßÇÑ)¼ö»ö;ޱ¸;Á¶»ç;¿¬±¸ ´É·Â;¿¬±¸½É;¿¬±¸ÇÏ´Ù;Á¶»çÇÏ´Ù;~able
  • research and development
    ¿¬±¸¿Í °³¹ß
  • research laboratory(institute)
    ¿¬±¸¼Ò
  • research library
    ¿¬±¸ µµ¼­°ü ´Â
  • research paper
    ¿¬±¸ ³í¹®;(ÇлýÀÇ)Çб⸻ ¸®Æ÷Æ®
  • research professor
    ¿¬±¸ ±³¼ö(´ëÇÐ µî¿¡¼­ ÀÚÀ¯·ÎÀÌ ¿¬±¸¿¡ ¸ôµÎÇÒ ¼ö ÀÖ´Â ±³¼ö)
  • research reactor
    ¿¬±¸¿ë ¿øÀÚ·Î
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á